Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Palliative techniques for hepatic cancer.

Daniel T Ruan1, Robert S Warren

  • 1Department of Surgery, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.

Surgical Oncology Clinics of North America
|July 9, 2004
PubMed
Summary

For advanced liver cancer, liver-directed therapies offer palliative options when surgery isn't possible. These treatments aim to manage symptoms and improve survival for unresectable hepatic malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metastatic colorectal adenocarcinoma tumor purity assessment from whole exome sequencing data.

PloS one·2023
Same author

STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20.

Journal of cellular and molecular medicine·2022
Same author

RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon.

Cancer discovery·2020
Same author

A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors.

Journal of surgical oncology·2020
Same author

Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.

Journal of surgical oncology·2019
Same author

Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.

Journal of surgical oncology·2019

Area of Science:

  • Hepatology
  • Oncology
  • Interventional Radiology

Background:

  • Primary and secondary hepatic malignancies represent a significant cause of cancer-related mortality.
  • Surgical resection, a curative option, is feasible only for a small subset of patients with liver cancer.
  • Effective palliative strategies are crucial for managing symptoms and prolonging survival in unresectable cases.

Purpose of the Study:

  • To review liver-directed therapy options for patients diagnosed with advanced, unresectable liver malignancies.
  • To highlight treatments that can minimize tumor-related symptoms and extend overall survival.
  • To provide an overview of current palliative approaches beyond systemic chemotherapy.

Main Methods:

  • Literature review of studies on liver-directed therapies for unresectable liver cancer.
  • Analysis of treatment modalities focusing on palliative care and survival extension.
  • Synthesis of evidence regarding the efficacy and application of various liver-directed interventions.

Main Results:

  • Systemic chemotherapy demonstrates modest efficacy in symptom amelioration and survival improvement for advanced liver cancer.
  • Liver-directed therapies offer alternative palliative strategies for patients ineligible for surgery.
  • Specific interventional techniques and locoregional treatments are explored for managing unresectable hepatic malignancies.

Conclusions:

  • Liver-directed therapies are essential for palliative management of advanced unresectable liver malignancies.
  • These treatments aim to improve quality of life and potentially extend survival when curative options are not available.
  • Further research into optimizing liver-directed therapies is warranted to enhance outcomes for this patient population.

Related Experiment Videos